- A phase I study of recombinant human interleukin-4 administered by the intravenous and subcutaneous route in patients with advanced cancer: immunological studies. Ghosh, A.K., Smith, N.K., Prendiville, J., Thatcher, N., Crowther, D., Stern, P.L. Eur. Cytokine Netw. (1993)